Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VPMCX vs OZEM overlap: 16% of top holdings shared

Bottom line

How much do VPMCX and OZEM overlap?

16% of their top holdings overlap by weight. 3 securities appear in both funds' top 25, making up 10.7% of VPMCX's assets and 20.4% of OZEM's. They are substantially different portfolios, so owning both adds real diversification.

VPMCX holds far more positions (173 vs 26), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

VPMCXOZEM
Weight overlap (top 25)16%
Shared holdings3
Weight in shared holdings10.7%20.4%
Total positions17326
Expense ratio0.35%0.59%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings VPMCX and OZEM have in common

Holding% of VPMCX% of OZEMOverlap
Eli Lilly & Co6.76%12.69%6.76%
AstraZeneca PLC2.35%3.83%2.35%
Amgen Inc1.64%3.85%1.64%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VPMCX

  1. Micron Technology Inc — 13.50%
  2. Intel Corp — 6.80%
  3. KLA Corp — 3.85%
  4. Alphabet Inc — 3.52%
  5. NVIDIA Corp — 2.33%
  6. Amazon.com Inc — 2.05%
  7. Tesla Inc — 1.89%
  8. Biogen Inc — 1.88%
  9. Siemens AG — 1.88%
  10. Texas Instruments Inc — 1.85%
  11. FedEx Corp — 1.70%
  12. Microsoft Corp — 1.67%
  13. Charles Schwab Corp/The — 1.49%
  14. Ross Stores Inc — 1.48%
  15. Vanguard Cmt Funds-Vanguard Market Liquidity Fund — 1.46%

Only in OZEM

  1. Novo Nordisk A/S — 12.96%
  2. Mount Vernon Liquid Assets Portfolio, LLC — 9.93%
  3. Pfizer Inc — 6.38%
  4. Kailera Therapeutics Inc — 6.21%
  5. Viking Therapeutics Inc — 5.86%
  6. CSPC Pharmaceutical Group Ltd — 5.32%
  7. Chugai Pharmaceutical Co Ltd — 4.51%
  8. Ascletis Pharma Inc — 4.20%
  9. Zealand Pharma A/S — 3.92%
  10. Hanmi Pharm Co Ltd — 3.50%
  11. Structure Therapeutics Inc — 3.05%
  12. Roche Holding AG — 3.03%
  13. MBX Biosciences Inc — 2.80%
  14. United Lab — 2.63%
  15. Jiangsu Hengrui Pharmaceutical — 2.58%

Asset mix

Asset typeVPMCXOZEM
Stocks98.5%99.6%
Cash & short-term funds1.6%10.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryVPMCXOZEM
US96.6%54.8%
DK—18.8%
CN—17.0%
JP—5.8%
GB0.3%3.8%
KR—3.5%
CH0.3%3.0%
HK—2.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do VPMCX and OZEM overlap?
About 16% by weight. 3 securities appear in both funds' top 25 holdings; they make up 10.7% of VPMCX's assets and 20.4% of OZEM's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do VPMCX and OZEM have in common?
The largest shared holdings are Eli Lilly & Co, AstraZeneca PLC, Amgen Inc.
Should I own both VPMCX and OZEM?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, VPMCX or OZEM?
VPMCX is broader, with 173 positions versus 26 for OZEM. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.